Dyslipidemia in patients with HIV
Abstract Since the introduction of highly active antiretroviral therapy (ART) in the treatment of HIV/AIDS patients, we have observed a change in the development of the disease, becoming a chronic therapeutically containable condition. The increase in survival goes together with associated...
Guardado en:
| Autores principales: | , , , |
|---|---|
| Formato: | Artículo revista |
| Lenguaje: | Español |
| Publicado: |
Escuela de Salud Pública y Ambiente. Fac. Cs. Médicas UNC
2015
|
| Materias: | |
| Acceso en línea: | https://revistas.unc.edu.ar/index.php/RSD/article/view/11733 |
| Aporte de: |
| Sumario: | Abstract Since the introduction of highly active antiretroviral therapy (ART) in the treatment of HIV/AIDS patients, we have observed a change in the development of the disease, becoming a chronic therapeutically containable condition. The increase in survival goes together with associated diseases; cardiovascular ones have become relevant, being earlier and more severe. Dyslipidemias have a leading role in this pathology. In this work, we analyze their incidence and characteristics in HIV patients, with and without ART treatment. Lipid profile was different in the pre-treatment stage (low HDL, low total Cholesterol and normal TG) from the stage under ART (marked increase of TG and to a lesser extent of total Cholesterol and LDL), with a significant association of the use of Protease Inhibitors (PIs) and CD4 levels lower than 200/mm3. |
|---|